Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Ingelman-Sundberg

Showing results (61-70 of 284) with videos related to

Pageof 29
Sort By:
Pharmacogenetics and Genomics|September 5, 2015
Genetic variation in the human cytochrome P450 supergene familyKohei Fujikura, Magnus Ingelman-Sundberg, Volker M Lauschke
Biochemical and Biophysical Research Communications|October 30, 2016
The role of microRNAs in liver injury at the crossroad between hepatic cell death and regenerationVolker M Lauschke, Souren Mkrtchian, Magnus Ingelman-Sundberg
Clinical Pharmacology and Therapeutics|June 29, 2022
Liquid Biopsies or Therapeutic Drug Monitoring for CYP Activity Profile DeterminationChris S Pridgeon, Inger Johansson, Magnus Ingelman-Sundberg
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 22, 2016
Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug responseMikael Kozyra, Magnus Ingelman-Sundberg, Volker M Lauschke
Toxicology and Applied Pharmacology|July 1, 2005
Novel extrahepatic cytochrome P450sMaria Karlgren, Shin-ichi Miura, Magnus Ingelman-Sundberg
Pharmacology & Therapeutics|January 25, 2019
Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicityVolker M Lauschke, Yitian Zhou, Magnus Ingelman-Sundberg
Annual Review of Pharmacology and Toxicology|July 28, 2023
Pharmacogenomics Beyond Single Common Genetic Variants: The Way ForwardVolker M Lauschke, Yitian Zhou, Magnus Ingelman-Sundberg
Drug Metabolism Reviews|June 4, 2016
The CYP2W1 enzyme: regulation, properties and activation of prodrugsJia Guo, Inger Johansson, Souren Mkrtchian, et al.
Biochemistry|December 10, 2003
Identification of sequences responsible for intracellular targeting and membrane binding of rat CYP2E1 in yeastEtienne P A Neve, Mats Hidestrand, Magnus Ingelman-Sundberg
JAMA|August 15, 2006
Coffee, myocardial infarction, and CYP nomenclatureMagnus Ingelman-Sundberg, Sarah C Sim, Daniel W Nebert
Pageof 29

Showing results (61-70 of 284) with videos related to

Sort By:
Pageof 29
Pharmacogenetics and Genomics|September 5, 2015
Genetic variation in the human cytochrome P450 supergene familyKohei Fujikura, Magnus Ingelman-Sundberg, Volker M Lauschke
Biochemical and Biophysical Research Communications|October 30, 2016
The role of microRNAs in liver injury at the crossroad between hepatic cell death and regenerationVolker M Lauschke, Souren Mkrtchian, Magnus Ingelman-Sundberg
Clinical Pharmacology and Therapeutics|June 29, 2022
Liquid Biopsies or Therapeutic Drug Monitoring for CYP Activity Profile DeterminationChris S Pridgeon, Inger Johansson, Magnus Ingelman-Sundberg
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 22, 2016
Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug responseMikael Kozyra, Magnus Ingelman-Sundberg, Volker M Lauschke
Toxicology and Applied Pharmacology|July 1, 2005
Novel extrahepatic cytochrome P450sMaria Karlgren, Shin-ichi Miura, Magnus Ingelman-Sundberg
Pharmacology & Therapeutics|January 25, 2019
Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicityVolker M Lauschke, Yitian Zhou, Magnus Ingelman-Sundberg
Annual Review of Pharmacology and Toxicology|July 28, 2023
Pharmacogenomics Beyond Single Common Genetic Variants: The Way ForwardVolker M Lauschke, Yitian Zhou, Magnus Ingelman-Sundberg
Drug Metabolism Reviews|June 4, 2016
The CYP2W1 enzyme: regulation, properties and activation of prodrugsJia Guo, Inger Johansson, Souren Mkrtchian, et al.
Biochemistry|December 10, 2003
Identification of sequences responsible for intracellular targeting and membrane binding of rat CYP2E1 in yeastEtienne P A Neve, Mats Hidestrand, Magnus Ingelman-Sundberg
JAMA|August 15, 2006
Coffee, myocardial infarction, and CYP nomenclatureMagnus Ingelman-Sundberg, Sarah C Sim, Daniel W Nebert
Pageof 29